Tactile Systems Technology Inc is a medical technology company... Show more
A.I.dvisor indicates that over the last year, TCMD has been loosely correlated with CSTL. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if TCMD jumps, then CSTL could also see price increases.
| Ticker / NAME | Correlation To TCMD | 1D Price Change % | ||
|---|---|---|---|---|
| TCMD | 100% | +1.42% | ||
| CSTL - TCMD | 50% Loosely correlated | +1.21% | ||
| UFPT - TCMD | 46% Loosely correlated | +2.74% | ||
| IRMD - TCMD | 43% Loosely correlated | -1.37% | ||
| AORT - TCMD | 43% Loosely correlated | +1.48% | ||
| SIBN - TCMD | 39% Loosely correlated | +1.64% | ||
More | ||||
| Ticker / NAME | Correlation To TCMD | 1D Price Change % |
|---|---|---|
| TCMD | 100% | +1.42% |
| Medical/Nursing Services industry (138 stocks) | 1% Poorly correlated | -2.46% |
| Health Services industry (238 stocks) | 1% Poorly correlated | -3.33% |
a medical devices developer
Industry MedicalNursingServices
TCMD's Aroon Indicator triggered a bullish signal on November 02, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 234 similar instances where the Aroon Indicator showed a similar pattern. In 204 of the 234 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 87%.
TCMD moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for TCMD crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 10 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 80%.
Following a +2.03% 3-day Advance, the price is estimated to grow further. Considering data from situations where TCMD advanced for three days, in 211 of 269 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
The 10-day RSI Indicator for TCMD moved out of overbought territory on November 12, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 40 similar instances where the indicator moved out of overbought territory. In 27 of the 40 cases, the stock moved lower in the following days. This puts the odds of a move lower at 68%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 41 of 62 cases where TCMD's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 66%.
The Momentum Indicator moved below the 0 level on November 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on TCMD as a result. In 68 of 99 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 69%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TCMD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.
TCMD broke above its upper Bollinger Band on November 03, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. TCMD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 65 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 68 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.634) is normal, around the industry mean (4.142). P/E Ratio (23.881) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.290) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (1.458) is also within normal values, averaging (40.124).
The Tickeron PE Growth Rating for this company is 77 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TCMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.